Tomás Conechny

Ask VT AI
View News Summary
  • Novo Nordisk's weight-loss drug CagriSema shows promising results, but market reaction is mixed due to expectations set by competitors' drugs.
  • Trump administration replaces Biden-era CBP One app with new CBP Home app to facilitate self-deportation of illegal immigrants in the US.
  • Deliveroo to exit Hong Kong amid rising competition from local players like KeeTa, launched by Meituan, which surpassed Deliveroo in order volume.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk's weight-loss drug CagriSema shows promising results, but market reaction is mixed due to expectations set by competitors' drugs.
  • Trump administration replaces Biden-era CBP One app with new CBP Home app to facilitate self-deportation of illegal immigrants in the US.
  • Deliveroo to exit Hong Kong amid rising competition from local players like KeeTa, launched by Meituan, which surpassed Deliveroo in order volume.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Tomás Conechny